SHOULDER INNOVATIONS INC (SI)
Health Care · orthopedic medical devices · NYSE
Shoulder Innovations develops orthopedic devices for shoulder and upper extremity conditions, showing explosive revenue growth but facing profitability challenges and dramatic stock depreciation.
What SHOULDER INNOVATIONS INC does
Shoulder Innovations is a healthcare company focused on orthopedic innovation, specifically addressing shoulder and upper extremity conditions. The company develops and commercializes medical devices and solutions for shoulder-related pathologies. With 151% YoY revenue growth, the company is in scaling phase but currently unprofitable.
Themes: ["orthopedic devices","shoulder surgery","medical devices"]
Fundamentals
- Price$21.23 as of 2026-07-09 close
- Market cap$440M as of 2026-07-10
- 1-year return-98.9% as of 2026-07-09 close
- Net margin-17.1% as of 2026-07-10
- Gross margin+77.0% as of 2026-07-10
- ROE-13.6% as of 2026-07-10
- Debt / equity0.11 as of 2026-07-10
- Revenue growth (YoY)+151.0% as of 2026-07-10
- Beta14.77 as of 2026-07-10
Key risks (from latest filing)
["Rapidly changing competitive orthopedic device market with established competitors","Company is unprofitable with -17.14% net margin despite strong revenue growth","Severe stock price decline of -98.93% over 1 year despite revenue expansion suggests significant operational or market challenges"]
Competitors & peers
- Zimmer Biomet (ZBH)
- Stryker Corporation (SYK)
- Smith & Nephew (SNN)
- DePuy Synthes
- Arthrex
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.